Barrett Elizabeth A.
SEC insider (Form 3/4/5 filer). CIK 0001764157. Director at Allogene Therapeutics, Inc. (ALLO) and 2 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Barrett Elizabeth A. has filed insider reports for
- Allogene Therapeutics, Inc. (ALLO): Director
- UroGen Pharma Ltd. (URGN): Officer, Chief Executive Officer
- Sage Therapeutics, Inc. (SAGE): Director
Barrett Elizabeth A.
CIK: 0001764157
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 18, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
95.4K shares- - Jan 31, 2026URGN
UroGen Pharma Ltd.
AwardDirectRestricted Stock Units
153.2K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
Tender OfferDirect3K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
21.5K shares- - Jul 28, 2025URGN
UroGen Pharma Ltd.
AwardDirectPerformance Stock Units
87.6K shares- - Jun 18, 2025ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
95.4K shares- - Jun 11, 2025SAGE
Sage Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21.5K shares- - Jan 31, 2025URGN
UroGen Pharma Ltd.
AwardDirectRestricted Stock Units
96.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  ALLO Allogene Therapeutics, Inc. | Award Restricted Stock Unit | 95,400 | - | - | Direct |
| Jan 31, 2026 |  URGN UroGen Pharma Ltd. | Award Restricted Stock Units | 153,195 | - | - | Direct |
| Jul 31, 2025 |  SAGE Sage Therapeutics, Inc. | Tender Offer | 3,000 | - | - | Direct |
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 21,500 | - | - | Direct |
| Jul 28, 2025 | URGN UroGen Pharma Ltd. | Award Performance Stock Units | 87,615 | - | - | Direct |
| Jun 18, 2025 | ALLO Allogene Therapeutics, Inc. | Award Restricted Stock Unit | 95,400 | - | - | Direct |
| Jun 11, 2025 | SAGE Sage Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,500 | - | - | Direct |
| Jan 31, 2025 | URGN UroGen Pharma Ltd. | Award Restricted Stock Units | 96,377 | - | - | Direct |
1-8 of 8 transactions